Trial record 1 of 4 for:
Liberty 1
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03049735 |
Recruitment Status :
Active, not recruiting
First Posted : February 10, 2017
Last Update Posted : August 9, 2019
|
Sponsor:
Myovant Sciences GmbH
Information provided by (Responsible Party):
Myovant Sciences GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | April 25, 2019 |
Estimated Study Completion Date : | December 30, 2019 |